Comerica Bank Bluebird Bio, Inc. Transaction History

Comerica Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $798 - $2,922	605 New	605 $0
Q3 2019 Oct 31, 2019	SELL	$59.47 - $93.1 $114,182 - $178,752	-1,920 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$75.84 - $105.21 $1,820 - $2,525	-24 Reduced 1.23%	1,920 $0
Q1 2019 May 02, 2019	BUY	$64.44 - $104.11 $1,739 - $2,810	27 Added 1.41%	1,944 $0
Q4 2018 Feb 06, 2019	SELL	$59.1 - $93.26 $6,441 - $10,165	-109 Reduced 5.38%	1,917 $237,000
Q3 2018 Nov 01, 2018	BUY	$88.86 - $117.49 $10,929 - $14,451	123 Added 6.46%	2,026 $240,000
Q2 2018 Aug 01, 2018	BUY	$99.64 - $127.59 $17,437 - $22,328	175 Added 10.13%	1,903 $345,000
Q1 2018 May 01, 2018	SELL	$105.8 - $150.94 $5,713 - $8,150	-54 Reduced 3.03%	1,728 $295,000
Q4 2017 Feb 02, 2018	BUY	$81.25 - $130.7 $6,012 - $9,671	74 Added 4.33%	1,782 $370,000
Q3 2017 Nov 06, 2017	BUY	$57.74 - $91.42 $98,619 - $156,145	1,708	1,708 $242,000

146

63.3M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $644M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.